| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT07427394 Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With… |
Recruitment opened |
| 2026-05-20 | NCT06760637 Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-20 | NCT06760637 Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast… |
Trial sites reduced: 518 -> 463 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06760637 | Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast… | Breast Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT04606446 | Study of PF-07248144 in Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic ER+ HER2- Breast Cancer | Recruiting |
| NCT07427394 | Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With… | Advanced Breast Cancer | Recruiting |
| Phase 1/2 | |||
| NCT03424005 | A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients… | Metastatic Breast Cancer | Recruiting |
| NCT06206837 | A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced… | Breast Cancer | Active, Not Recruiting |